CHUCK SHOLTZ

Chuck Sholtz, J.D., Ph.D. has 30 years of IP experience representing clients in both law firm and corporate settings in patent and other intellectual property matters.  He is currently Vice President, Intellectual Property at Nutcracker Therapeutics and co-teaches a Biotechnology Law class at Santa Clara University School of Law.

Prior to Nutcracker, Chuck was Director, Biosimilars, and Manufacturing IP Lead at Genentech, heading up a team of patent agents and attorneys supporting Genentech’s cell culture, process development and manufacturing organizations.  In his role, Chuck also participated on the team managing Genentech’s response in the JHL trade secrets misappropriations case.

Before Genentech, Chuck served as Vice President, Intellectual Property at Coherus Biosciences, a biosimilars company, where he developed FTO positions for potential new products and managed both patent and trade secrets litigation. 

Prior to Coherus, Chuck spent 8 years as an IP attorney at Amgen in a number of roles, including Large Molecule Team co-lead and Neuroscience Therapeutic Area IP Team Lead.

Chuck earned a B.S. in Cell & Molecular Biology and a B.S.E. in Engineering Science (Bioengineering) from the University of Michigan, a Masters degree in Physiology from Yale University, a Ph.D. in Neuroscience from Stanford University, and a J.D. from Santa Clara University School of Law.